MedCity News
FEBRUARY 10, 2025
AI can be a highly effective tool for plans aiming to reduce fraud, waste and abuse, but only if it is combined with investigative intelligence. The post AI: A Good Tool to Combat Bad Actors in Healthcare appeared first on MedCity News.
PharmaVoice
FEBRUARY 12, 2025
As drug development priorities shift, pharma companies need to understand younger patients to improve their reputation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
FEBRUARY 11, 2025
Novartis has agreed to acquire Anthos Therapeutics, Inc., and will gain rights to a potential first-in-class biologic. Anthos has been developing the monoclonal antibody abelacimab as a treatment to prevent stroke and systemic embolism in individuals with atrial fibrillation, under a license from Novartis. The therapy is designed to induce effective haemostasis-sparing anticoagulation through Factor XI inhibition, preventing the activated form (Factor XIa) being generated.
Scott Burrows
FEBRUARY 11, 2025
When you think of the qualities that make an elite athlete, you might immediately think of strength, speed, and skill. But theres something else that plays a crucial role in both sports and business: mindset. At 19, I was living my dream as a wide receiver for Florida State University and a champion kickboxer. But then, in the blink of an eye, I found myself paralyzed from the chest down after a car accident.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
MedCity News
FEBRUARY 12, 2025
The consequences for not prioritizing new guidelines for CKD screening have a devastating impact on population health by increasing the global mortality rate and driving higher healthcare costs. The post Prioritizing CKD Screening Guidelines is Imperative to Combat Global Health Crisis appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
European Pharmaceutical Review
FEBRUARY 12, 2025
The European Commission has approved acoramidis as the first near complete TTR stabiliser (90 percent) to treat transthyretin amyloidosis in adults with cardiomyopathy (ATTR-CM) patients in the US and EU. BEYONTTRA (acoramidis) is indicated for adults with wild-type or variant ATTR-CM. This disease is progressively fatal and results in heart failure, BridgeBio Pharma, Inc. explained.
Evolve Your Success
FEBRUARY 13, 2025
Think you need a science degree to succeed in medical sales? Think again. This episode dismantles the biggest myths in the industry and gives you the blueprint to win, regardless of your background. What’s Inside: How top reps are skipping degrees and dominating through passion and relationships Why ex-servers, chefs, and sales pros are pivoting into high-paying med sales roles The raw truth about the grindregulations, quotas, and why it’s not about fancy dinners The secret skills t
MedCity News
FEBRUARY 13, 2025
We need apps that have been tested with real users to ensure they are intuitive and easy to use. The apps also need to be designed to be inclusive of different needs including patients with disabilities, different levels of tech literacy, and diverse needs. The post Building Patient Trust in Digital Health Software appeared first on MedCity News.
PharmaVoice
FEBRUARY 11, 2025
What will it take for a clinical-stage biotech to break into the cardio space? One CEO thinks he has the answer.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
European Pharmaceutical Review
FEBRUARY 13, 2025
New analysis by VTT Technical Research Centre of Finland has highlighted the EUs completely underestimated costs of the newly enforced Urban Wastewater Treatment Directive. Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
David Bagga
FEBRUARY 10, 2025
Break into Medical device Sales Factors influencing entry level sales salaries Would you like to start a sales career? Want to know how much you will get paid? Whether you’re interested in medical device sales compensation or the average sales salary and commission, it’s useful to know what still affects your paycheck. Sales careers canbe […] The post Factors influencing entry level sales salaries appeared first on.
MedCity News
FEBRUARY 13, 2025
Medicare Advantage plans can more effectively position themselves for success under an evolving measurement system. Here are three strategic actions health plan leaders should prioritize to enhance 2026 bids to secure stronger Star Rating performance. The post The New Game Plan for Star Ratings Must Start with Member Incentives appeared first on MedCity News.
PharmaVoice
FEBRUARY 10, 2025
Fractyl Health is entering pivotal studies for a procedure that aims to be an ‘off ramp’ to GLP-1s and exploring how a one-time, ‘smart GLP-1’ gene therapy can Treat type 2 diabetes.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmaTech
FEBRUARY 10, 2025
Pharmaceutical Technology sat down with Michelle Bridenbaker, COO of Unbiased Science, ahead of International Day of Women and Girls in Science to talk about the role of women in the pharmaceutical industry.
PharmaTimes
FEBRUARY 10, 2025
New methodology may boost innovation in protein engineering
MedCity News
FEBRUARY 12, 2025
Integrating nursing expertise into technology design, development, and implementation fosters early user support, establishes credibility with the technology, and leads to significantly better usage across the organization, avoiding the creation of process workarounds. The post The Nurse as Designer: Breaking Down Barriers with Clinician-Center Innovation appeared first on MedCity News.
PharmaVoice
FEBRUARY 10, 2025
An emerging class of orexin-based drugs are on the cusp of disrupting care for sleep disorders — and potentially much more.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
FEBRUARY 12, 2025
Merck acquisition target SpringWorks will go toe-to-toe with AstraZeneca in the US neurofibromatosis market.
PharmaTimes
FEBRUARY 10, 2025
CSL Behring's study reveals significant long-term benefits
MedCity News
FEBRUARY 11, 2025
The Anthos Therapeutics acquisition represents a homecoming for its drug abelacimab, which originated in Novartiss labs. The antibody offers the potential to prevent blood clots without the bleeding risks associated with currently available anticoagulants. The post Novartiss $925M Anthos Acquisition Brings Back Cardio Drug That Stops Blood Clots appeared first on MedCity News.
PharmaTech
FEBRUARY 11, 2025
Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
FEBRUARY 13, 2025
The US Senate today confirmed Robert F Kennedy Jr as Health and Human Services Secretary, after a vote that largely followed party lines.
PharmaTimes
FEBRUARY 13, 2025
Imaging agent to improve prostate cancer detection
MedCity News
FEBRUARY 13, 2025
GLP-1 drugs dominate the obesity market, but Aardvark Therapeutics aims to curb appetite by going after a different target: TAS2 receptors in the gut. The biotechs lead drug candidate is in Phase 3 testing in Prader-Willi syndrome, a genetic disorder that causes persistent hunger leading to overeating. The post Aardvark Therapeutics Pursuit of New Obesity Target Adds $94M in IPO Cash appeared first on MedCity News.
Pharmaceutical Technology
FEBRUARY 11, 2025
Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront payment of $925m.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
pharmaphorum
FEBRUARY 10, 2025
AbbVie has won FDA approval for Emblaveo, a new antibiotic to treat pathogens that pose serious public health threats.
PharmaTimes
FEBRUARY 12, 2025
UCB's BIMZELX reveals promising two-year data at EHSF 2025
MedCity News
FEBRUARY 12, 2025
SpringWorks Therapeutics Gomekli is now FDA approved for treating tumors caused by the rare genetic disorder neurofibromatosis type 1. The approval comes as SpringWorks has emerged as a potential acquisition target. The post FDA Approval of Drug for Rare Tumors Enables SpringWorks to Challenge AstraZeneca appeared first on MedCity News.
Expert insights. Personalized for you.
300 
Let's personalize your content